✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthSystematic ReviewEvidence QualityClinical GuidelinesResearch Gaps Why This MattersSystematic reviews in major journals like...
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthEvidence QualitySystematic ReviewClinical Decision-MakingPatient Counseling Why This MattersThis systematic review highlights a persistent...
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With Few Clear Benefits
There is a crucial need for more high-quality research. Given the scarcity of evidence, the routine use of cannabinoids for the treatment of mental disorders and SUDs is currently rarely justified.
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans a wide range of study types, with most data coming from observational research rather than controlled trials. The existing literature suggests both...
Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Mental HealthEvidence QualityClinical ResearchTherapeutic EfficacyPsychiatric Applications Why This Matters This finding reinforces the...
Endocannabinoid System Research: Cannabinoids in Pediatric Care
Clinical Takeaway Existing clinical evidence on cannabinoid use in children spans hundreds of studies across multiple designs, reflecting growing but still evolving data on both safety and effectiveness. The breadth of study...
Endocannabinoid System Research: Cannabis for Chronic Pain
Clinical Takeaway Clinical trials show that cannabis-based products, particularly those with higher THC content, provide modest reductions in chronic pain compared to placebo, though the overall strength of evidence remains low to...
Endocannabinoid System: Cannabis for Chronic Pain Evidence
Clinical Takeaway Cannabinoids, particularly products with measurable THC content, show modest but consistent evidence for reducing chronic pain compared to placebo in randomized controlled trials, though the overall certainty of evidence remains...
Cannabis-Based Products for Chronic Pain: Clinical Evidence
Clinical Takeaway Clinical trials show that cannabis-based products containing THC provide modest reductions in chronic pain compared to placebo, though the overall quality of evidence remains low to moderate. The benefit appears...